GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
Megadott ok: The study was terminated due to the interim analysis demonstrating lack of treatment efficacy.
Key facts
- Where
- Augusta, Baltimore, Bellaire, Bellevue, Beverly Hills, Boston, Chesterfield, Cincinnati, Dallas, Fort Myers, Great Neck, Indianapolis, Lemont, Marietta, Morgantown, New York, Palo Alto, Philadelphia, Phoenix, Portland, Reno, Rochester, Salt Lake City, Silverdale, Spokane, St. Petersburg, The Woodlands, Tucson, Vauxhall, West Des Moines, Willow Park és Winston-Salem, Egyesült ÁllamokSee the 33 sites
Where in Egyesült Államok
- Southeast Retina CenterAugusta, Egyesült ÁllamokNo longer taking part
- Johns Hopkins University School Of MedicineBaltimore, Egyesült ÁllamokNo longer taking part
- The Retina Care CenterBaltimore, Egyesült ÁllamokNo longer taking part
- Retina Consultants of Houston-TMCBellaire, Egyesült ÁllamokNo longer taking part
- Proliance Retina (formally known as Vitreoretinal Associates of Washington)Bellevue, Egyesült ÁllamokNo longer taking part
- Retina-Vitreous Associates Medical GroupBeverly Hills, Egyesült ÁllamokNo longer taking part
- Ophthalamic Consultants of Boston (OCB)Boston, Egyesült ÁllamokNo longer taking part
- Pepose Vision InstituteChesterfield, Egyesült ÁllamokNo longer taking part
- Cincinnati Eye InstituteCincinnati, Egyesült ÁllamokNo longer taking part
- Retina Foundation of the SouthwestDallas, Egyesült ÁllamokNo longer taking part
- Retina Health CenterFort Myers, Egyesült ÁllamokNo longer taking part
- Long Island Vitreoretinal ConsultantsGreat Neck, Egyesült ÁllamokNo longer taking part
- Midwest Eye Institute NorthsideIndianapolis, Egyesült ÁllamokNo longer taking part
- University Retina Macula Associates PCLemont, Egyesült ÁllamokNo longer taking part
- Georgia Retina PCMarietta, Egyesült ÁllamokNo longer taking part
- West Virginia UniversityMorgantown, Egyesült ÁllamokNo longer taking part
- Columbia University Medical CenterNew York, Egyesült ÁllamokNo longer taking part
- Byers Eye Institute at StanfordPalo Alto, Egyesült ÁllamokNo longer taking part
- Mid Atlantic RetinaPhiladelphia, Egyesült ÁllamokNo longer taking part
- Retinal Research Institute (retina consultants of AZ)Phoenix, Egyesült ÁllamokNo longer taking part
- Casey Eye Institute - OHSUPortland, Egyesült ÁllamokNo longer taking part
- Sierra Eye AssociatesReno, Egyesült ÁllamokNo longer taking part
- Retina Association of Western New YorkRochester, Egyesült ÁllamokNo longer taking part
- Retina Associates of UtahSalt Lake City, Egyesült ÁllamokNo longer taking part
- Retina Center NorthwestSilverdale, Egyesült ÁllamokNo longer taking part
- Spokane Eye Clinical ResearchSpokane, Egyesült ÁllamokNo longer taking part
- Retina Vitreous Associates of FloridaSt. Petersburg, Egyesült ÁllamokNo longer taking part
- Retina Consultants of HoustonThe Woodlands, Egyesült ÁllamokNo longer taking part
- Retina Centers PCTucson, Egyesült ÁllamokNo longer taking part
- New Jersey Retina Research FoundationVauxhall, Egyesült ÁllamokNo longer taking part
- Wolfe Eye ClinicWest Des Moines, Egyesült ÁllamokNo longer taking part
- Strategic Clinical Research LLCWillow Park, Egyesült ÁllamokNo longer taking part
- Wake Forest Baptist Medical Center - Wake Forest University School of MedicineWinston-Salem, Egyesült ÁllamokNo longer taking part
Trial details
- Who runs it
- Gyroscope Therapeutics Limited
- Trial code
- NCT03894020
- Record updated
- 2024. október 30.
- Original description
An observational study to evaluate the natural progression of dry AMD in genetically defined subjectsRead full original descriptionShow less
A Study of Disease Progression in Genetically Defined Subjects With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
An observational study to evaluate the natural progression of dry AMD in genetically defined subjects
Inclusion: Adults with unilateral or bilateral Geographic Atrophy (GA) due to Age-related Macular Degeneration (AMD); BCVA of 40 letters or better using ETDRS charts.
Exclusion: Participation in another research study involving an investigational product within the previous 4 weeks or 5 half-lives whichever is longer from the screening/baseline OR received a gene/cell therapy at any time previously; Significant ocular or non-ocular disease that would impact the subject's ability to participate in the study; Evidence or history of neovascular Age-related Macular Degeneration (AMD) or diabetic retinopathy.